The Pioneering Role of GATA2 in Androgen Receptor Variant Regulation Is Controlled by Bromodomain and Extraterminal Proteins in Castrate-Resistant Prostate Cancer. (2019)
Attributed to:
MICA: Characterisation of a novel bromodomain inhibitor AZD5153 in castrate resistant prostate cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1541-7786.mcr-18-1231
PubMed Identifier: 30833300
Publication URI: http://europepmc.org/abstract/MED/30833300
Type: Journal Article/Review
Volume: 17
Parent Publication: Molecular cancer research : MCR
Issue: 6
ISSN: 1541-7786